Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) T.ATE

Alternate Symbol(s):  ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


TSX:ATE - Post by User

Comment by AntibeTribeon Feb 08, 2021 7:31pm
157 Views
Post# 32508238

RE:Share activity

RE:Share activity
Jefnan1 wrote: There is no way today's activity has anything to do with the opening bell. I read the daily comments on here and can't believe the people who think the share movements either up or down have anything to do with the factors that  effect a mature company on a daily basis. This is a speculative drug development company so if you believe the proof of concept than you shouldn't care what happens on a daily basis. 


Obviously the opening bell didn't move the SP today. That's dumb. I dont think anyone here believes that's the case.. (+$.85 on a bell opening?? Shouldn't we just play opening bells everyday then? Lol)But nonetheless, something did act as a catalyst for the upward movement today.
We have traded sideways for months. Struggling with the $4 mark as a hurdle since the offering. (June 30, 2020)So with no news announced, aside from that of the opening bell, and nothing else changing today, we are left to assume that , as it was also today, the bell may have had a correlated affect on the SP. I personally don't think this is the case at all, and that bigger things are happening in the short term behind the curtain. Time will tell.
<< Previous
Bullboard Posts
Next >>